NCT06820359 Bowel Preparation in Minimally Invasive Gynecologic Surgery
| NCT ID | NCT06820359 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Muhammad Aslam |
| Condition | Gynecologic Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 166 participants |
| Start Date | 2025-02-17 |
| Primary Completion | 2026-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 166 participants in total. It began in 2025-02-17 with a primary completion date of 2026-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowel handling, intestinal load and ease of surgery will be assessed. Patient comfort and satisfaction will be assessed.
Eligibility Criteria
Inclusion Criteria: * Scheduled to undergo minimally invasive robotic gynecologic surgery; * Age 18 years and above * Willing to perform an enema if randomized to the enema group * Able to read and understand English * Willing to sign an informed consent form Exclusion Criteria: * Scheduled for open surgery * Younger than 18 years of age * Unwilling to perform an enema if randomized to the enema group * Unable to read and understand English * Unwilling to sign an informed consent form
Contact & Investigator
Muhammad Aslam, MD
PRINCIPAL INVESTIGATOR
Henry Ford Health
Frequently Asked Questions
Who can join the NCT06820359 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Gynecologic Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06820359 currently recruiting?
Yes, NCT06820359 is actively recruiting participants. Contact the research team at maslam2@hfhs.org for enrollment information.
Where is the NCT06820359 trial being conducted?
This trial is being conducted at Detroit, United States, Warren, United States.
Who is sponsoring the NCT06820359 clinical trial?
NCT06820359 is sponsored by Muhammad Aslam. The principal investigator is Muhammad Aslam, MD at Henry Ford Health. The trial plans to enroll 166 participants.